A detailed history of Invesco Ltd. transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 55,339 shares of MDXG stock, worth $503,584. This represents 0.0% of its overall portfolio holdings.

Number of Shares
55,339
Previous 58,332 5.13%
Holding current value
$503,584
Previous $404,000 19.06%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$5.65 - $7.76 $16,910 - $23,225
-2,993 Reduced 5.13%
55,339 $327,000
Q2 2024

Aug 13, 2024

SELL
$6.16 - $8.08 $2.58 Million - $3.39 Million
-419,309 Reduced 87.79%
58,332 $404,000
Q1 2024

May 14, 2024

BUY
$7.61 - $8.63 $175,775 - $199,335
23,098 Added 5.08%
477,641 $3.68 Million
Q4 2023

Feb 12, 2024

BUY
$5.7 - $9.14 $128,711 - $206,390
22,581 Added 5.23%
454,543 $3.99 Million
Q3 2023

Nov 13, 2023

SELL
$6.35 - $8.16 $239,642 - $307,950
-37,739 Reduced 8.03%
431,962 $3.15 Million
Q2 2023

Aug 11, 2023

BUY
$3.14 - $6.61 $1.35 Million - $2.84 Million
429,442 Added 1066.7%
469,701 $3.1 Million
Q1 2023

May 12, 2023

SELL
$2.97 - $4.81 $141,146 - $228,590
-47,524 Reduced 54.14%
40,259 $137,000
Q4 2022

Feb 13, 2023

BUY
$2.63 - $3.45 $130,729 - $171,489
49,707 Added 130.55%
87,783 $244,000
Q3 2022

Nov 14, 2022

SELL
$2.71 - $4.22 $54 - $84
-20 Reduced 0.05%
38,076 $109,000
Q2 2022

Aug 15, 2022

SELL
$3.17 - $5.0 $12,321 - $19,435
-3,887 Reduced 9.26%
38,096 $132,000
Q1 2022

May 16, 2022

SELL
$4.27 - $6.27 $2,732 - $4,012
-640 Reduced 1.5%
41,983 $197,000
Q4 2021

Feb 14, 2022

SELL
$5.7 - $8.48 $40,281 - $59,928
-7,067 Reduced 14.22%
42,623 $257,000
Q3 2021

Nov 15, 2021

BUY
$5.52 - $15.83 $52,561 - $150,733
9,522 Added 23.71%
49,690 $300,000
Q2 2021

Aug 17, 2021

BUY
$9.02 - $12.72 $362,315 - $510,936
40,168 New
40,168 $502,000

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $1.03B
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.